📰 Gamida Cell News
Page 6 - Gamida Cell News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gamida Cell. Real-time updates on events, politics, business and more.
July 11, 2023
Faster immune reconstitution and decreased rate of post-transplant viral infection in patients transplanted with Omisirge versus umbilical cord blood
July 11, 2023
11.07.2023 - Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the publication in press of a prospective sub-study of the Phase 3 clinical trial for Omisirge (omidubicel-onlv), the company’s ... Seite 1
July 10, 2023
/PRNewswire/ -- Stand Up To Cancer® (SU2C) today announced that Julian Adams, Ph.D., a longtime oncology researcher and retired pharmaceutical industry chief...
July 6, 2023
Gamida Cell Ltd. (NASDAQ:GMDA – Free Report) was the target of a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 4,270,000 shares, a growth of 34.3% from the May 31st total of 3,180,000 shares. Based on an average daily volume of 5,350,000 shares, the […]
July 4, 2023
Gamida Cell Ltd. (NASDAQ:GMDA – Free Report) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 4,270,000 shares, an increase of 34.3% from the May 31st total of 3,180,000 shares. Based on an average daily trading volume, of 5,350,000 shares, the days-to-cover ratio […]
July 4, 2023
Gamida Cell Ltd. (NASDAQ:GMDA – Free Report) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 4,270,000 shares, an increase of 34.3% from the May 31st total of 3,180,000 shares. Based on an average daily trading volume, of 5,350,000 shares, the days-to-cover ratio […]
July 4, 2023
Gamida Cell Ltd. (NASDAQ:GMDA – Free Report) saw a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 4,270,000 shares, an increase of 34.3% from the May 31st total of 3,180,000 shares. Based on an average daily trading volume, of 5,350,000 shares, the short-interest ratio […]
June 14, 2023
Thought leaders Dr. Steven Devine and Dr. Usama Gergis to share perspectives on unmet needs and the clinical landscape in stem cell transplant Update on the progress of the commercial launch for... | June 14, 2023
June 14, 2023
BOSTON--(BUSINESS WIRE)--Jun 14, 2023--
June 5, 2023
Elicio Therapeutics reports positive interim results from a Phase 1 trial at risk of relapse after surgery or chemotherapy.